DIFFERENT BY DESIGN

Each patient’s journey is unique.
Every product requires a new roadmap.
Let’s connect the dots together.

PX3 AXS is transforming the possibilities

We’re making a real difference—backed by real results—in launching complex products.

Our mission is to provide trailblazing solutions
for novel medicines by connecting the dots to transform the experience of patients living with difficult-to-treat diseases.

Organizations are turning to PX3 AXS and our renowned thought leadership. Where strategic goals are aligned with insights and data to build custom commercialization frameworks.

DIFFERENT BY DESIGN

Each patient’s journey is unique.
Every product requires a new roadmap.
Let’s connect the dots together.

PX3 AXS is transforming the possibilities

We’re making a real difference—backed by real results—in launching complex products.

Our mission is to provide trailblazing solutions for novel medicines by connecting the dots to transform the experience of patients living with difficult-to-treat diseases.

Organizations are turning to PX3 AXS and our renowned thought leadership. Where strategic goals are aligned with insights and data to build custom commercialization frameworks.

TAILOR-MADE ROADMAPS FOR SUCCESS

Our strategic consulting services are helping to reshape the health care and pharmaceutical industry. Major advances in technology have paved the way for novel products and unique customer experiences to be introduced, ranging from new treatments for ultra-rare conditions to personalized cancer therapies.

The complexity of novel products requires us to rethink the entire commercialization model, redefine how value should be articulated, and most importantly, integrate perspectives for the optimal patient experience.

TAILOR-MADE ROADMAPS FOR SUCCESS

Our strategic consulting services are helping to reshape the health care and pharmaceutical industry. Major advances in technology have paved the way for novel products and unique customer experiences to be introduced, ranging from new treatments for ultra-rare conditions to personalized cancer therapies.

The complexity of novel products requires us to rethink the entire commercialization model, redefine how value should be articulated, and most importantly, integrate perspectives for the optimal patient experience.

BUILD COMMERCIALIZATION STRATEGIES

The questions often start with the fundamentals due to the complexity of these novel therapies and often not well-understood conditions.

What is the true size of the patient population where this product can have the greatest positive impact?
What is their current diagnostic and treatment experience, and how will these novel treatments change it?
How do we modify our organizational structure to ensure commercialization success?

We focus on generating insights to build a foundational strategy informing the commercialization model for success at launch and beyond.

Here’s what we do:

  • Patient Identification Assessment
  • Patient Experience Literature Review
  • Clinical Trial Optimization
  • Ecosystem Mapping and Account Prioritization
  • Advocacy Assessment and Strategy
  • Internal and External Commercialization Model Development
  • Strategic Consultations

REDEFINE VALUE AND ACCESS

The payer approach to an assessment of a product’s value is still based on traditional clinical trial design and process to review safety and efficacy data, as well as costs. However, novel treatments often require clinical trial programs to be conducted utilizing unconventional methods due to the complexities of the technologies, limited patient populations, and lack of appropriate comparators.

How do we translate complex clinical data commercially in a way that’s easily understood?
Do the clinical endpoints demonstrate important benefits to stakeholders?
How do we assess value and communicate these outcomes in a meaningful way?

We help by developing a multi-dimensional approach to redefining value across all relevant stakeholders to ensure patient access to treatment.

Here’s what we do:

  • US & HTA Product Coverage Assessment
  • Product Value Positioning Strategy
  • Pricing Assessment
  • Patient Affordability Analysis
  • Value Assessment Advisory Team
  • Value Story Platform Tailored by Audience
  • Payer Evidence Portals
  • Development of Marketing Materials

MASTER PATIENT EXPERIENCES

For novel treatments, the key to success is building a superior patient experience throughout the treatment journey and beyond.

How can we understand the patient experience, which is often limited by data, to best determine who will benefit from personalized therapy?
What strategies should we employ to reach the multi-disciplinary treatment team in the various settings of care?
How do we effectively engage with caregivers and patients to reflect their personal preferences and create the optimal experience?

We help by not only uncovering all the details, but also identifying the gaps and solutions to create the optimal patient experience.

Here’s what we do:

  • Patient and Caregiver Advisory Councils
  • Patient Experience Mapping
  • Patient Support Strategy
  • Patient Support Framework and Operational Support
  • Omnichannel Strategy
  • Patient Engagement Resources
  • Healthcare Quality Programs
  • Connection to Marketing Campaigns

BUILD COMMERCIALIZATION STRATEGIES

The questions often start with the fundamentals due to the complexity of these novel therapies and often not well-understood conditions.

What is the true size of the patient population where this product can have the greatest positive impact?
What is their current diagnostic and treatment experience, and how will these novel treatments change it?
How do we modify our organizational structure to ensure commercialization success?

We focus on generating insights to build a foundational strategy informing the commercialization model for success at launch and beyond.

Here’s what we do:

  • Patient Identification Assessment
  • Patient Experience Literature Review
  • Clinical Trial Optimization
  • Ecosystem Mapping and Account Prioritization
  • Advocacy Assessment and Strategy
  • Internal and External Commercialization Model Development

REDEFINE VALUE AND ACCESS

The payer approach to an assessment of a product’s value is still based on traditional clinical trial design and process to review safety and efficacy data, as well as costs. However, novel treatments often require clinical trial programs to be conducted utilizing unconventional methods due to the complexities of the technologies, limited patient populations, and lack of appropriate comparators.

How do we translate complex clinical data commercially in a way that’s easily understood?
Do the clinical endpoints demonstrate important benefits to stakeholders?
How do we assess value and communicate these outcomes in a meaningful way?

We help by developing a multi-dimensional approach to redefining value across all relevant stakeholders to ensure patient access to treatment.

Here’s what we do:

  • US & HTA Product Coverage Assessment
  • Product Value Positioning Strategy
  • Pricing Assessment
  • Patient Affordability Analysis
  • Value Assessment Advisory Team
  • Value Story Platform Tailored by Audience
  • Payer Evidence Portals

MASTER PATIENT EXPERIENCES

For novel treatments, the key to success is building a superior patient experience throughout the treatment journey and beyond.

How can we understand the patient experience, which is often limited by data, to best determine who will benefit from personalized therapy?
What strategies should we employ to reach the multi-disciplinary treatment team in the various settings of care?
How do we effectively engage with caregivers and patients to reflect their personal preferences and create the optimal experience?

We help by not only uncovering all the details, but also identifying the gaps and solutions to create the optimal patient experience.

Here’s what we do:

  • Patient and Caregiver Advisory Councils
  • Patient Experience Mapping
  • Patient Support Strategy
  • Patient Support Framework and Operational Support
  • Omnichannel Strategy
  • Patient Engagement Resources
  • Healthcare Quality Programs
  • Connection to Marketing Campaigns

BIG IDEAS…

BOUTIQUE IDEALS

Clients partner with us because we listen to their needs and unique challenges. No two strategies are ever exactly alike. Our highly experienced team is reshaping the future of commercialization—one disease at a time.

The PX3 AXS members you meet from day one will be your team all along the way. We’re big proponents of building the right chemistry with our partners.

Our collaborative group was carefully considered to help clients who share our same fearless vision—to create revolutionary patient experiences. Together.

BIG IDEAS…

BOUTIQUE IDEALS

Clients partner with us because we listen to their needs and unique challenges. No two strategies are ever exactly alike. Our highly experienced team is reshaping the future of commercialization—one disease at a time.

The PX3 AXS members you meet from day one will be your team all along the way. We’re big proponents of building the right chemistry with our partners.

Our collaborative group was carefully considered to help clients who share our same fearless vision—to create revolutionary patient experiences. Together.

We’re:

Passionate

about making a real
difference in
difficult-to-treat diseases

Experienced

in shaping complex
launches in the
sciences

Focused

on translating
insights into
actionable strategies

Unrivaled

with
breakthrough
thinking

Dedicated

to providing
superior client
service

We’re:

Passionate

about making a real
difference in
difficult-to-treat diseases

Experienced

in shaping complex
launches in the
sciences

Focused

on translating
insights into
actionable strategies

Unrivaled

with
breakthrough
thinking

Dedicated

to providing
superior client
service

We’re:

Passionate

about making a real
difference in
difficult-to-treat diseases

Experienced

in shaping complex
launches in the
sciences

Focused

on translating
insights into
actionable strategies

Unrivaled

with
breakthrough
thinking

Dedicated

to providing
superior client
service

CONNECT WITH US

Let’s chat about your organization’s goals and how PX3 AXS can help you to redefine the entire patient journey.

Email or call Renata Reis, Managing Director.

  • info@px3axs.com

  • (833) 377-9930

CONNECT
WITH US

Let’s chat about your organization’s goals and how PX3 AXS can help you to redefine the entire patient journey.

Email or call Renata Reis, Managing Director.

  • info@px3axs.com

  • (833) 377-9930

Or send us a note. We’d love to hear from you.

Please enable JavaScript in your browser to complete this form.

Or send us a note.
We’d love to hear from you.

Please enable JavaScript in your browser to complete this form.